SEC Form 4 · accession 0001562180-18-003060
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lisa D Earnhardt
Officer — President and CEO · Director
Period of report
Jun 15, 2018
Accepted (ET)
Jun 19, 2018 · 5:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 15, 2018 | M | 5,000 | $13.05 | A | 489,683 | D | |
| Common StockF2 | Jun 15, 2018 | S | 20,000 | $36.7855 | D | 469,683 | D | |
| Common StockF3 | holding | — | — | — | 26,182 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $13.05 | Jun 15, 2018 | M | 5,000 | D | — | Jan 17, 2027 | Common Stock | 5,000 | 187,000 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.55 to $37.05, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- F3Shares in the name of Lisa Damkroger Earnhardt C/F Jack L. Earnhardt UTMA/CA Until Age 25 for the benefit of Reporting Person's son. Reporting Person disclaims beneficial ownership of these shares.
- F4The vesting commencement date of the option is January 1, 2017. 1/8th of the shares subject to the option shall vest on July 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months.